FDA’s Second Continuous Marketing Application Pilot Program Nearly 50% Enrolled
This article was originally published in The Pink Sheet Daily
Executive Summary
Nine divisions have not yet selected their application for the pilot program, which involves frequent scientific feedback and interactions with FDA during the IND phase of product development. Applications are being accepted through the end of September.